BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25610806)

  • 1. Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in individuals classified as low-risk according to Framingham.
    Hargens TA; Rhodes PG; VanReenen J; Kaminsky LA
    Cardiovasc Diagn Ther; 2014 Dec; 4(6):487-94. PubMed ID: 25610806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A
    Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
    Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
    Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
    Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Lipoprotein-associated phospholipase A2 With Carotid Intima-Media Thickness in Acute Cerebral Infarction Patients.
    Liang L; Chen J; Zhang C; Luo B; Zhou T; Wang X; Wang Y
    Angiology; 2024 Feb; ():33197241233774. PubMed ID: 38424714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Lipoprotein-Associated Phospholipase A2 and Inflammatory Markers in Subclinical Atherosclerosis in Premature Ovarian Failure Patients.
    Cekici Y; Kilic S; Ovayolu A; Saracoglu E; Duzen İV; Yilmaz M; Kaya BC; Bozkurt D
    Acta Cardiol Sin; 2021 Jan; 37(1):30-37. PubMed ID: 33488025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review.
    Younus A; Humayun C; Ahmad R; Ogunmoroti O; Kandimalla Y; Aziz M; Malik R; Saand AR; Valdes C; Badlani R; Younus MA; Ali SS; Chen Y; Nasir K
    J Clin Lipidol; 2017; 11(2):328-337. PubMed ID: 28502488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
    Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
    PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of ultrasound detected carotid atherosclerosis in subjects with low Framingham risk score: potential implications for screening for subclinical atherosclerosis.
    Naqvi TZ; Mendoza F; Rafii F; Gransar H; Guerra M; Lepor N; Berman DS; Shah PK
    J Am Soc Echocardiogr; 2010 Aug; 23(8):809-15. PubMed ID: 20554155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utility of the Lipoprotein-Associated Phospholipase A
    Mayne ES; Moabi H; Grobbee DE; Barth RE; Klipstein-Grobusch K; Stevens WS; Vos AG; Louw S
    Clin Appl Thromb Hemost; 2019; 25():1076029619883944. PubMed ID: 31686546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis.
    Li D; Wei W; Ran X; Yu J; Li H; Zhao L; Zeng H; Cao Y; Zeng Z; Wan Z
    Clin Chim Acta; 2017 Aug; 471():38-45. PubMed ID: 28514697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
    Li Y
    Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease.
    Sofogianni A; Alkagiet S; Tziomalos K
    Curr Pharm Des; 2018; 24(3):291-296. PubMed ID: 29332572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
    Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
    Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].
    Safarova MS; Trukhacheva EP; Ezhov MV; Afanas'eva OI; Afanas'eva MI; Tripoten' MI; Liakishev AA; Pokrovskiĭ SN
    Kardiologiia; 2011; 51(5):9-16. PubMed ID: 21649590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.